Literature DB >> 16821588

Cell cycle control by p21, p27 and p53 in Merkel cell carcinoma.

Virve Koljonen1, Erkki Tukiainen, Caj Haglund, Tom Böhling.   

Abstract

Merkel cell carcinoma (MCC) is an aggressive dermal tumour of neuroendocrine origin with poor prognosis. The role of cell cycle-regulatory proteins (p53/p21/p27) in MCC pathogenesis and their prognostic importance were evaluated. Twenty-four primary MCC specimens with corresponding clinical data were analysed by immunohistochemistry for p21, p27 and p53 antibodies. The stainings were evaluated semi-quantitatively and the results analysed statistically. p53 was negative in 80% and p21 in 71% of the samples. Positive staining for p27 was evident in 92% of the samples. However, the expression of these antibodies did not correlate with the outcome of the patient. The proportion of p53- and p21-negative samples seems to indicate that correction processes after DNA damage are not activated during MCC pathogenesis, a supposition that is supported by the aggressive nature of this tumour. Therefore, the expressions of the three studied cell cycle regulators cannot serve as prognostic markers for survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16821588

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Bcl-2 expression indicates better prognosis of Merkel cell carcinoma regardless of the presence of Merkel cell polyomavirus.

Authors:  Helka Sahi; Virve Koljonen; Heli Kavola; Caj Haglund; Erkki Tukiainen; Harri Sihto; Tom Böhling
Journal:  Virchows Arch       Date:  2012-09-14       Impact factor: 4.064

2.  [Merkel cell carcinoma].

Authors:  F Kleffner; J Schürholz; S Burckhardt; C Mauch; M Schlaak
Journal:  Hautarzt       Date:  2014-09       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.